Evidence map›Paper›PMID 17785772›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2007

Cutting edge: selective tyrosine dephosphorylation of interferon-activated nuclear STAT5 by the VHR phosphatase.

Richard Hoyt, Wei Zhu, Fabio Cerignoli, Andres Alonso, Tomas Mustelin, Michael David

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Dual-Specificity Phosphatases in Immunity and Infection: An Update.International journal of molecular sciences · 2019
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Richard HoytDivision of Biological Sciences, University of California La Jolla, CA 92093, USA.
Wei Zhu
Fabio Cerignoli
Andres Alonso
Tomas Mustelin
Michael David
Sanford Burnham Prebys Medical Discovery Institute · USUniversity of California San Diego · US

Funding

INTRACELLULAR SIGNALING BY INTERFERONSR01CA080105 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DAVID, MICHAEL · 1999 to 2006
$1.7M
NCI NIH HHS R01 CA080105NCI NIH HHS R01 CA80105
6 · The paper itself

Abstract

Cytokine-induced tyrosine phosphorylation of the transcription factor STAT5 is required for its transcriptional activity. In this article we show that the small dual-specificity phosphatase VHR selectively dephosphorylates IFN-alpha- and beta-activated, tyrosine-phosphorylated STAT5, leading to the subsequent inhibition of STAT5 function. Phosphorylation of VHR at Tyr(138) was required for its phosphatase activity toward STAT5. In addition, the Src homology 2 domain of STAT5 was required for the effective dephosphorylation of STAT5 by VHR. The tyrosine kinase Tyk2, which mediates the phosphorylation of STAT5, was also responsible for the phosphorylation of VHR at Tyr(138).

Indexed as

Cell LineCell NucleusDual Specificity Phosphatase 3HeLa CellsHumansInterferon-alphaInterferon-betaPhosphoprotein PhosphatasesPhosphorylationProtein Tyrosine PhosphatasesSTAT1 Transcription FactorSTAT5 Transcription FactorTyrosineDual Specificity Phosphatase 3DUSP3 protein, humanInterferon-alphaInterferon-betaPhosphoprotein PhosphatasesProtein Tyrosine PhosphatasesSTAT1 Transcription FactorSTAT5 Transcription FactorTyrosine

Identifiers

PMID17785772
PMCPMC2770724
OpenAlexW1491559816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.